Skip to content

To map the 3D clone map and 3D molecular margin of Hepatocellular carcinoma

mapping and application of 3D clone map and 3D molecule margin of Hepatocellular carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012362
Enrollment
Unknown
Registered
2017-08-14
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

control group:local excision depends on different Pathological status

Sponsors

Easten Hepatobiliary Surgery Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-85 years; Participating in the study voluntary,and sign the informed consent; 2. Geting the definite diagnose of hepatic carcinoma by B-mode ultrasonic CTMRI and blood analysis; 3. Without evident dieases of heart,lung,kidney; 4. The function of liver is CHILD pugh A or nearly,without neoplasm metastasis; 5. Accord with the standard of radical operation;radical surgery; 6. the tumor diameter is between 3-5cm.

Exclusion criteria

Exclusion criteria: 1. Rejecting to according with the standard; 2. Viloating the study; 3. Deficiency of major observe marker; 4. Undering some treatments such as TACE, PRFA/PMCT, chemoradiotherapy preoperative, and somebody who suffer from serious complications intraoperative or afteroperation.

Design outcomes

Primary

MeasureTime frame
recurrence rate;

Countries

China

Contacts

Public ContactWang Kui

Eastern Hepatobiliary Surgery Hospital Second Military Medical University

wangkuiykl@163.com+86 021-81875514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026